Berberine in the treatment of metabolism-related chronic diseases: A drug cloud (dCloud) effect to target multifactorial disorders-Reference-Cited by-同舟云学术

Berberine in the treatment of metabolism-related chronic diseases: A drug cloud (dCloud) effect to target multifactorial disorders

Published:2020-05 Issue: Volume:209 Page:107496
ISSN:0163-7258
Container-title:Pharmacology & Therapeutics
language:en
Short-container-title:Pharmacology & Therapeutics

Author:

Kong Wei-Jia,Vernieri Claudio,Foiani Marco,Jiang Jian-Dong

Funder

National Science Foundation of China

CAMS Major Collaborative Innovation Project

Publisher

Elsevier BV

Subject

Pharmacology (medical),Pharmacology

Reference106 articles.

1. A possible link of gut microbiota alteration in type 2 diabetes and Alzheimer's disease pathogenicity: An update;Alam;CNS & Neurological Disorders Drug Targets,2014

2. Current understanding of metformin effect on the control of hyperglycemia in diabetes;An;The Journal of Endocrinology,2016

3. Blood pressure reduction and clinical outcomes with angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers: Protocol for a systematic review and meta-regression analysis;Batty;Systematic Reviews,2018

4. Risk of bias in systematic reviews of non-randomized studies of adverse cardiovascular effects of thiazolidinediones and cyclooxygenase-2 inhibitors: Application of a new cochrane risk of bias tool;Bilandzic;PloSMed,2016

5. Berberine metabolites exhibit triglyceride-lowering effects via activation of AMP-activated protein kinase in Hep G2 cells;Cao;Journal of Ethnopharmacology,2013

Cited by 53 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unraveling the mechanism of ethyl acetate extract from Prismatomeris connata Y. Z. Ruan root in treating pulmonary fibrosis: insights from bioinformatics, network pharmacology, and experimental validation;Frontiers in Immunology;2024-01-08

2. Synthesis of New Derivatives of Berberine Canagliflozin and Study of Their Antibacterial Activity and Mechanism;Molecules;2024-01-04

3. Berberine protects mice against type 2 diabetes by promoting PPARγ-FGF21-GLUT2-regulated insulin sensitivity and glucose/lipid homeostasis;Biochemical Pharmacology;2023-12

4. Nephroprotective Efficacy of Echinops spinosus against a Glycerol-Induced Acute Kidney Injury Model;ACS Omega;2023-10-23

5. Intestines-erythrocytes-mediated bio-disposition deciphers the hypolipidemic effect of berberine from Rhizoma Coptidis: A neglected insight;Journal of Ethnopharmacology;2023-10